论文信息 - First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody®-CD3×CD20) in B-Cell Non-Hodgkin Lymphomas - 字舞流文

First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody®-CD3×CD20) in B-Cell Non-Hodgkin Lymphomas

P. Lugtenburg | M. Hutchings | S. Rule | A. Azaryan | R. Oliveri | M. Chamuleau | T. Ahmadi | K. Linton | R. Mous | I. Hiemstra | Guang Chen | D. DeMarco | M. Clausen | Manish Gupta | P. Johnson | Dena DeMarco